VICTORY CAPITAL MANAGEMENT INC
Position in NAGE — Niagen Bioscience, Inc.
CIK 1040188
San Antonio, TX
Position in NAGE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,876,111
-$161,709 QoQ
Shares Held
425,422
+32.8% QoQ
Ownership
0.534%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NAGE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026VICTORY CAPITAL MANAGEMENT INC holds $2,018,555,898 across 156 Biotechnology names. NAGE ranks #55 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,888,521 | $843,300,167 | |
| 2 | RPRX |
Royalty Pharma plc
|
3,853,808 | $184,867,169 | |
| 3 | INCY |
Incyte Corp
|
1,742,870 | $164,038,924 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
129,074 | $99,727,735 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,937 | $64,829,675 | |
| 6 | INSM |
INSMED Inc
|
396,245 | $64,793,982 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
303,224 | $60,538,671 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
256,598 | $48,509,851 |
All Filings in NAGE
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,876,111 | 425,422 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,037,820 | 320,412 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,536,004 | 378,993 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $5,873,977 | 407,632 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,536,485 | 222,679 | Shares | Sole | 2025-05-02 | |
| No filing history on record for this holder in this stock. | ||||||